Dispel Misinformation About Meds and Supplements for COVID-19

May 2020

Social media is aflutter with rumors about the impact of meds and supplements on COVID-19.

Clear up misinformation.

ACEIs and ARBs. You'll hear these meds increase the risk of getting COVID-19 or having serious complications from it.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Learn More

Already a subscriber? Log in

Not sold to individuals

Table of Contents

Practice Streamline Med Profiles for Patients in Isolation
Infectious Diseases Know the Roles of Remdesivir and IL-6 Inhibitors for COVID-19
Antibiotics Be Ready to Monitor Vancomycin With AUC/MIC Goals
Infectious Diseases Put Inpatient Hydroxychloroquine Use for COVID-19 in Perspective
Practice Enhance Communication During Virtual Interactions
Mental Health Share Coping Strategies With Distressed Colleagues
Infectious Diseases Dispel Misinformation About Meds and Supplements for COVID-19
Diabetes Meds Be Aware of SGLT2 Inhibitor Risks
New Drugs Feel Comfortable Holding Orexin Antagonists During Admission